Psychopharmacology of pediatric posttraumatic stress disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 9, Issue 3, 1999, Pages 203-220

  Donnelly, Craig L ^a   Amaya Jackson, Lisa ^b   March, John S ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; CYPROHEPTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GUANFACINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; OLANZAPINE; OPIATE ANTAGONIST; PAROXETINE; PHENELZINE; PROPRANOLOL; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN AGONIST; SERTRALINE; THIORIDAZINE; TRANQUILIZER; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ADOLESCENT; ADRENERGIC SYSTEM; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FOOD DRUG INTERACTION; GABAERGIC SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIMBIC SYSTEM; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOLOGY; SEROTONINERGIC SYSTEM; SLEEP DISORDER; TARDIVE DYSKINESIA; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032824446     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1999.9.203     Document Type: Article

References (112)

1. Allen AJ, Leonard H, Swedo S: Current knowledge of medications for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 34:976-986, 1995
2. Annsten, AFT: Development of the Cerebral Cortex: XIV. Stress impairs prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 38:220-222, 1999
3. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, Third Edition (DSM-III). Washington, DC, American Psychiatric Press, 1980
4. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, Fourth Edition (DSM-IV). Washington, DC, American Psychiatric Press, 1994
5. Arora RC, Fichtner CG, O'Connor F, Crayton JW: Paroxetine binding in the blood platelets of post-traumatic stress disorders patients. Life Sci 53:919-928, 1993
6. Arroyo W, Eth S: Children traumatized by Central American warfare. In Eth S, Pynoos RS. (eds.). Posttraumatic Stress Disorder in Children, Washington, DC: American Psychiatric Press, 1985, pp. 101-120
7. Benkelfat C: Serotonergic mechanisms in psychiatric disorders: New research tools, new ideas. Int Clin Psychopharmacol 8(Supplement 2):53-56, 1993
8. Biederman J: Clonazepam in the treatment of prpubertal children with panic-like symptoms. J Clin Psychiatry 48(Suppl):38-42, 1987
9. Black B, Robbins DR: Panic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 29:36-44, 1990
10. Bleich A, Koslowski M, Dolev A, Lorer B: PTSD and depression: An analysis of comorbidity. Br J Psychiatry 170:479-482, 1997
11. Brady KT: Posttraumatic stress disorder and comorbidity: Recognizing the many faces of PTSD. J Clin Psychiatry 58(Supplement):12-15, 1997
12. Bremner JD, Davis M, Southwick et al.: Neurobiology of posttraumatic stress disorder. In Oldham JM, Riba MB, Tasman A. (eds.). Review of Psychiatry. Washington, DC, American Psychiatric Press, 1993, pp. 183-205
13. Brent DA, Perper JA, Moritz G, et al.: Posttraumatic stress disorder in peers of adolescent suicide victims. J Am Acad Child Adolesc Psychiatry 34:209-215, 1995
14. Breslau N: Epidemiology of trauma and posttraumatic stress disorder in psychological trauma. In Yehuda R. (ed.). Washington, DC: American Psychiatric Press, 1998, pp. 1-29
15. Breslau N, Davis GC, Andreski P, Peterson E: Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 48:216-222, 1991
16. Brophy MH: Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder. Mil Med 156:100-101, 1991
17. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M: Psychobiological mechanisms of posttraumatic stress disorder. Archives Gen Psychiatry 50:294-305, 1993
18. Chronister RB, DeFrance JF: Functional organization of monoamines. In Palmer GC, (ed.). Neuropharmacology of Central Nervous System and Behavioral Disorders. New York: Academic Press, 1981, pp. 435-462
19. Coffey BJ: Anxiolytics for children and adolescents: Traditional and new drugs. J Child Adolesc Psychopharmacol 1:57-83, 1990
20. Cohen JA, Mannarino AP: A treatment outcome study for sexually abused preschool children: Initial findings. J Am Acad Child Adolesc Psychiatry 35:42-50, 1996
21. Connor KM, Davidson JRT: The role of serotonin in post-traumatic stress disorder: Neurobiology and pharmacotherapy. CNS Spectrums, The International Journal of Neuropsychiatric Medicine 3(7)(Suppl)42-51, 1998
22. Corrigan MH, Garbatt JC, Gillette GM, Mason G, Carson S, Golden RN: Serotonin and victims of childhood sexual abuse. New Research Abstracts. American Psychiatric Association, 143rd Annual Meeting, New York, NY, May 12-17, 1990
23. Cuffe SP, McCullough EL, Parmariega AJ: Comorbidity of attention deficit hyperactivity disorder and posttraumatic stress disorder. J Child Fam Stud 3:327-336, 1994
24. Davidson JR: Biological therapies for posttraumatic stress disorder: An overview. J Clin Psychiatry 58(Suppl)9:29-32, 1997
25. Davidson JR, Weisler RH, Malik ML, Connor MK: Treatment of posttraumatic stress disorder with nefazadone. Int Clin Psychopharmacology 13:111-113, 1998
26. De Bellis MD: Posttraumatic stress disorder and acute stress disorder. In Ammerman RT, Hersen M. (eds.). Handbook of Prevention and Treatment with Children and Adolescents: Intervention in the Real World Context, 1997, pp. 455-494
27. De Bellis MD, Putnam FW: The psychobiology of childhood maltreatment. Child and Adolescent Psychiatric Clinics of North America 3(4):663-678, 1994
28. De Bellis MD, Lefter L, Trickett PK, Putnam FW: Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry 33:320-327, 1994
29. Deblinger E, Lippman J, Steer: Sexually abused children suffering posttraumatic stress symptoms: Initial treatment outcome findings. Child Maltreatment 1:310-321, 1996
30. Deutch AY, Roth RH: The determinants of stress-induced activation of the prefrontal cortical dopamine system. In Uylings HBM, VanEden CG, DeBruin MA, (eds.). The Prefrontal Cortex: Its Structure, Function and Pathology. Amsterdam, Elsevier Science Publishers, 1989, pp. 367-403
31. Deykin EY, Buka SL: Prevalence and risk factors for posttraumatic stress disorder among chemically dependent adolescents. Am J Psychiatry 154:752-757, 1997
32. Drugen RC, Ryan SM, Minor TR, Maier SF: Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock. Pharmacol Biochem Behav 21:749-754, 1984
33. Ende N, Gertner SB, Socha B: Unexpected changes in urinary catecholamines and vanillylmandelic acid following rape assault. Horm Behav 24(1):62-70, 1990
34. Famularo R, Kinscherff R, Fenton T: Propranolol treatment for childhood post-traumatic stress disorder, acute type: A pilot study. Am J Dis Child 142:1244-1247, 1988
35. Feeney DJ, Klykylo W: Risperidone and tardive dyskinesia (letter). J Am Acad Child Adolesc Psychiatry 36(7):867, 1996
36. Fessier FA: Valproate in combat-related post-traumatic stress disorder. J Clin Psychiatry 52(9):361-364, 1991
37. Friedman MJ: Current and future drug treatment for post-traumatic stress disorder patients. Psychiatric Annals 28:8:461-468, 1998
38. Friedman MJ: Interrelationships between biological mechanisms and pharmacotherapy of post-traumatic stress disorder. In Wolfe ME, Mosnian AD (eds.) Post-traumatic Stress Disorder: Etiology, Phenomenology, and Treatment. Washington, DC: American Psychiatric Press:204-225, 1990
39. Friedman MJ, Southwick SM: Towards pharmacotherapy for post-traumatic stress disorder. In Friedman MJ, Chamey DS, Deutch AY (eds.). Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Lippincott-Raven Publishers, 1995, pp. 465-481
40. Friedman MJ, Charney DS, Deutch AY: Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Lippincott-Raven Press: Philadelphia, PA 1995
41. Garland FJ, Smith DH: Case study: Panic disorder on a child psychiatric consultation service. J Am Acad Child Adolesc Psychiatry 29:785-788, 1990
42. Giaconia RM, Reinherz HZ, Silverman AB, Pakiz B, Frost AK, Cohen E: Traumas and posttraumatic stress disorder in a community population of older adolescents. J Am Acad Child Adolesc Psychiatry 34:1369-1380, 1995
43. Gittleman-Klein R, Klein DF: Controlled imipramine treatment of school phobia. Arch Gen Psychiatry 25:204-207, 1971
44. Gittleman-Klein R, Klein DF: School phobia: Diagnostic considerations in the light of imipramine effects. J Nerve Ment Dis 156:199-215, 1973
45. Glod CA, Teicher MH: Relationship between early abuse, PTSD, and activity levels in prepubertal children. J Am Acad Child Adolesc Psychiatry 35:1384-1393, 1996
46. Glover H: Emotional numbing: A possible endorphin-medicated phenomenon associated with post-traumatic stress disorder and other allied psychopathological states. J Trauma Stress 5:643-675, 1992
47. Glover H: A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder. J Psychiatry Related Sci 30(4):225-263, 1993
48. Goenjian AK, Pynoos RS, Steinberg AM et al.: Psychiatric comorbidity in children after the 1988 earthquake in Armenia. J Am Acad Child Adolesc Psychiatry 34:1174-1184, 1995
49. Gonzalez-Heydrich J, Peroutka SJ: Serotonin receptor and reuptake sites: Pharmacologic significance. J Clin Psychiatry 51:5-12, 1990
50. Graae F, Milner J, Rizotto L, Klein RG: Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:372-376, 1994
51. Harmon RJ, Riggs PD: Clinical perspectives: Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adoles Psychiatry 35:1247-1249, 1996
52. Herman-Giddens ME, Sandler AD, Friedman NE: Sexual precocity in girls: An association with sexual abuse? Am J Dis Child 142:431, 1988
53. Herman JL, van der Kolk BA: Traumatic antecedents of borderline personality disorder. In: van der Kolk BA. (ed.). Psychological Trauma, Washington, DC: American Psychiatric Press, pp. 303-327, 1987
54. Hertzberg MA, Feldman ME, Beckham JC, Davidson JRT: Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 16:294-298, 1996
55. Horrigan JP: Guanfacine for posttraumatic stress disorder nightmares (letter). J Am Acad Child Adolesc Psychiatry 35:975-976, 1996
56. Horrigan JP, Barnhill LJ: The suppression of nightmares with guanfacine (Letter). J Clin Psychiatry 57:371, 1996
57. Hubbard J, Realmuto GM, Northwood AK, Masten AS: Comorbidity of psychiatric diagnosis with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 34:1167-1173, 1995
58. Jensen JB, Pease JJ, ten Bensel R, Garfinkel BD: Growth hormone response patterns in sexually or physically abused boys. J Am Acad Child Adolesc Psychiatry 30(5):784-790, 1991
59. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB: Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 52:1048-1060, 1995
60. Koren D, Arnon I, Klein E: Acute stress response and posttraumatic stress disorder in traffic accident victims: A one-year prospective, follow-up study. Am J Psychiatry 156:3;367-373, 1999
61. Kinzie JD, Leung P: Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 177:546-550, 1989
62. Kinzie JD, Sack W, Angell R, Manson S, Ben R: The psychiatric effects of massive trauma on Cambodian children: I The children. J Am Acad Child Adolesc Psychiatry 25:370-376, 1986
63. Kitchner I, Greenstein R: Low dose lithium carbonate in the treatment of post-traumatic stress disorder: Brief communication. Mil Med 150:378-381, 1985
64. Kolb LC, Burris BC, Griffiths S: Propranolol and clonidine in the treatment of the chronic posttraumatic stress disorders of war. In van der Kolk, BA, (ed.). Post-traumatic Stress Disorder: Psychological and Biological Sequelae. Washington, DC American Psychiatric Press, 1984, pp. 97-107
65. Kolko D: Individual cognitive-behavioral treatment and family therapy for physically abused children and their offending parents: A comparison of clinical outcomes. Child Maltreatment 1:322-342, 1996
66. Kulka RA, Schlenger WE, Fairbank JA, Jough RL, Jordan BK, Marmar CR, Weiss DS: Trauma and the Vietnam War Generation. New York: Brunner/Mazel, 1990
67. Kutcher S, Reiter S, Gardner D: Pharmacotherapy approaches and applications. In March JS. (ed.). Anxiety Disorders in Children and Adolescents. New York: Guilford, 1995, pp. 341-385
68. Kutcher S: Practitioner review: The pharmacotherapy of adolescent depression. J Child Psychol Psychiatry 38(7):755-767, 1997
69. Kutcher SP, Mackenzie S: Successful clonazepam treatment of adolescents with panic disorder (letter). J Clin Psychopharmacol 8:299-301, 1988
70. Kutcher SP, Reiter S, Gardner DM, Klein RG: The pharmacotherapy of anxiety disorders in children and adolescents. Psychiatr Clin North Am 15:41-67, 1992
71. Lipper S, Davidson JRT, Grady TA, Edingar JD, Hammett EB, Mahorney SL, Cavenar JO: Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 27:849-854, 1986
72. Loof D, Grimley P, Kuller F, Martin A, Shonfield L: Carbamazepine for PTSD (letter). J Am Acad Child Adolesc Psychiatry 34(6):703-704, 1995
73. March JS, Amaya-Jackson L, Murray MC, Schulte A: Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after single-incident stressor. J Am Acad Child Adolesc Psychiatry 37:585-593, 1998
74. Marmar CR, Schoenfeld F, Weiss DS: Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 14:79-81, 1996
75. Marmar CK, Foy D, Kagan B, Pynoos RS: An integrated approach for treating post-traumatic stress. In Pynoos RS, (ed.). Post-traumatic Stress Disorder: A Clinical Review. Sidran Press, Lutherville, Maryland, 1993, pp. 239-272
76. McDougle CJ, Southwick SM, Charney DS, St. James RL: An open clinical trial of fluoxetine in the treatment of post-traumatic stress disorder. J Clin Psychopharmacol 11:325-327, 1991
77. McGee MD: Cessation of self mutilation in a patient with borderline personality disorder treated with naltrexone (letter). J Clin Psychiatry 58:32-33, 1997
78. McLeer SV, Callaghan M, Henry D, Wallen J: Psychiatric disorders in sexually abused children. J Am Acad Child Adolesc Psychiatry 33:313-319, 1994
79. Nagy LM, Morgan CA, Southwick SM, Charney DS: Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 13:107-114, 1993
80. National Research Council: Understanding child abuse and neglect. Washington, DC: National Academy Press, 1993
81. Nutt DJ, Glue P, Lawson C: Flumazenil provocation of panic attacks: Evidence for altered benzodiazapine receptor in panic disorder. Arch Gen Psychiatry 47:917-925, 1990
82. Perry BD, Pollard RA, Blakely TL, Baker WL, Vigilante D: Childhood trauma, the neurobiology of adaptation, and "use dependent" development of the brain: How "states" become "traits." Inf Ment Health J 16:271-291, 1995
83. Perry, BD: Neurobiological sequelae of childhood trauma: PTSD in children. In: Murburg MM, (ed.). Catecholamine Function in Post-traumatic Stress Disorder: Emerging Concepts. Washington, DC: American Psychiatric Press, 233-255, 1994
84. Pfefferbaum B: Posttraumatic stress disorder in children: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36:11:1503-1511, 1997
85. Pitman RK, van der Kolk BA, Orr SP, Greenberg MS: Nalaxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. Arch Gen Psychiatry 47:541-544, 1990
86. Practice Parameters: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry Supplement 37:10:45-265, 1998
87. Putnam FW, Trickett PK: Child sexual abuse: A model of chronic trauma. Psychiatry 56:82-95, 1993
88. Reist C, Kauffmann CD, Haier RJ, Sangdahl C, Demet EM, Chicz-Demet A, Nelson JN: A controlled trial of despramine in 18 men with post-traumatic stress disorder. Am J Psychiatry 146:513-516, 1989
89. Rothbaum BO, Ninan PT, Thomas L: Sertraline in the treatment of rape victims with posttraumatic stress disorder. J Trauma Stress 9:865-871, 1996
90. Sapolsky RM, Plotsky PM: Hypercortisolism and its possible neural bases. Biol Psychiatry 27:937-952, 1990
91. Simeon JG, Ferguson HB, Knott V: Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoiant behaviors. J Am Acad Child Adolesc Psychiatry 31:29-33, 1992
92. Solomon Z, Bleich A: Comorbidity of posttraumatic stress disorder and depression in Israeli veterans. CNS Spectrums, The International Journal of Neuropsychiatrie Medicine 3(7)Supplement 2:15-21, 1998
93. Solomon SD, Davidson JRT: Trauma, prevalence impairment, service use, and cost. J Clin Psychiatry 58 (Supplement):5-11, 1997
94. Southwick SM, Yehuda R, Giller Charney DS: Use of tricyclics and monoamine oxidase inhibitors in the treatment of PTSD: A quantitative review. In Marburg MM, (ed.). Catecholamine Function in Post-Traumatic Stress Disorder: Emerging Concepts. Washington, DC: American Psychiatric Press, pp. 293-305, 1994
95. Southwick SM, Krystal JH, Morgan A: Yohimbine and M-chlorophenyl-piperazine in PTSD. New Research Abstracts. American Psychiatric Association, 144th Annual Meeting, New Orleans, Louisiana, May 11-16, 1991
96. Steiner H, Garcia IG, Matthews Z: Posttraumatic stress disorder in incarcerated juvenile delinquents. J Am Academy Child Adolesc Psychiatry 36:357-365, 1997
97. Teitz EI, Gomaz F, Berman RF: Amygdala kindled seizure stage is related to altered benzodiazepine binding site density. Life Sci 36:183-190, 1985
98. Terr, L: Childhood traumas: An outline and overview. Am J Psychiatry, 148:10-20, 1991
99. Uno H, Tarara R, Else J: Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 9:1705-1711, 1989
100. Van der Kolk BA, Greenberg MS, Orr SP: Endogenous opioids, stress induced analgesia and postttaumatic stress disorder. Psychopharmacol Bull 25:417-421, 1989
101. Van der Kolk BA: Psychopharmacological issues in post traumatic stress disorder. Hosp Community Psychiatry 34:683-691, 1983
102. Van der Kolk BA, Dreyfus D, Michaels M: Fluoxetine in post-traumatic stress disorder. J Clin Psychiatry 55:517-522, 1994
103. Van der Kolk BA, Perry JC, Herman JL: Childhood origins of self-destructive behavior. Am J Psychiatry 148:1655-1671, 1991
104. Ver Ellen P, van Kammen DP: The biological findings in post-traumatic stress disorder: A review. J Appl Soc Psychology 20:1789-1821, 1990
105. Wells GB, Chu C, Johnson R: Buspirone in the treatment of post-traumatic stress disorder. J Clin Psychiatry 55:517-522, 1991
106. Yehuda R: Recent developments in the neuroendocrinology of posttraumatic stress disorder. CNS Spectrums, The International Journal of Neuropsychiatrie Medicine 3(7)Suppl 2:22-29, 1998
107. Yehuda R, McFarlane AC: Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am J Psychiatry 152:1705-1713, 1995
108. Yehuda R, Giller EL, Southwick SM, Kahana B, Boisoneau D, Ma X, Mason JW: Relationship between catecholamine excretion and PTSD symptoms in Vietnam veterans and holocaust survivors. In: Murburg MM, (ed.). Catecholamine Function in Post-traumatic Stress Disorder: Emerging Concepts. Washington, DC: American Psychiatric Press, 1994, pp. 203-219
109. Yehuda R, Giller EL, Southwick SM: Hypothalamic pituitary adrenal axis dysfunction in PTSD. Biol Psychiatry 30:1031-1048, 1991
110. Yeo HM, Yeo WW: Repeated deliberate self-harm: A link with childhood sexual abuse? Arch Emerg Med 10:161-166, 1993
111. Zohar J, Yehuda S, Amital D, Inacu I, Zinger Y: Current diagnostic issues and epidemiological insights in PTSD. CNS Spectrums, The International Journal of Neuropsychiatrie Medicine 3(7)Suppl 2:11-14, 1998
112. Zwier KJ, Rao U: Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type). J Am Acad Child Adolesc Psychiatry 33:1007-1011, 1994